135 related articles for article (PubMed ID: 35926158)
1. Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes.
Nasioudis D; Taunk NK; Ko EM; Haggerty AF; Cory L; Giuntoli RL; Kim SH; Latif NA
Am J Clin Oncol; 2022 Sep; 45(9):373-378. PubMed ID: 35926158
[TBL] [Abstract][Full Text] [Related]
2. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
Xiang M; English DP; Kidd EA
Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
[TBL] [Abstract][Full Text] [Related]
3. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion.
Son J; Chambers LM; Carr C; Michener CM; Yao M; Beavis A; Yen TT; Stone RL; Wethington SL; Fader AN; Burkett WC; Richardson DL; Staley AS; Ahn S; Gehrig PA; Torres D; Dowdy SC; Sullivan MW; Modesitt SC; Watson C; Veade A; Ehrisman J; Havrilesky L; Secord AA; Loreen A; Griffin K; Jackson A; Viswanathan A; Ricci S
Int J Gynecol Cancer; 2020 Nov; 30(11):1738-1747. PubMed ID: 32771986
[TBL] [Abstract][Full Text] [Related]
5. Role of brachytherapy in stage III endometrial cancer treated with adjuvant chemotherapy: Identifying factors predictive of a survival benefit.
Xiang M; English DP; Kidd EA
Brachytherapy; 2021; 20(4):701-709. PubMed ID: 33781714
[TBL] [Abstract][Full Text] [Related]
6. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
Nagar H; Yan W; Parashar B; Nori D; Chao KS; Christos P; Gupta D; Holcomb K; Caputo T; Wernicke AG
Am J Clin Oncol; 2016 Aug; 39(4):335-9. PubMed ID: 27028349
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma.
Xiang M; Kidd EA
J Gynecol Oncol; 2020 Jul; 31(4):e39. PubMed ID: 31912686
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus.
Onstad M; Ducie J; Fellman BM; Abu-Rustum NR; Leitao M; Mariani A; Multinu F; Lu KH; Soliman P
Int J Gynecol Cancer; 2020 Apr; 30(4):485-490. PubMed ID: 31980487
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of sentinel lymph node mapping for patients with FIGO stage I endometrioid endometrial carcinoma.
Nasioudis D; Byrne M; Ko EM; Giuntoli RL; Haggerty AF; Cory L; Kim SH; Morgan MA; Latif NA
Gynecol Oncol; 2021 Jun; 161(3):705-709. PubMed ID: 33771397
[TBL] [Abstract][Full Text] [Related]
11. Overuse of external beam radiotherapy for stage I endometrial cancer.
Wright JD; Margolis B; Hou JY; Burke WM; Tergas AI; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL
Am J Obstet Gynecol; 2016 Jul; 215(1):75.e1-7. PubMed ID: 26875941
[TBL] [Abstract][Full Text] [Related]
12. Role of adjuvant chemotherapy in patients with FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma treated with surgery and post-operative radiotherapy.
Reshko LB; Gaskins JT; Dryden SM; Metzinger DS; Todd SL; Eldredge-Hindy HB; Silva SR
Int J Gynecol Cancer; 2021 May; 31(5):694-701. PubMed ID: 33741653
[TBL] [Abstract][Full Text] [Related]
13. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.
van Weelden WJ; Reijnen C; Eggink FA; Boll D; Ottevanger PB; van den Berg HA; van der Aa MA; Pijnenborg JMA
Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
Beavis AL; Yen TT; Stone RL; Wethington SL; Carr C; Son J; Chambers L; Michener CM; Ricci S; Burkett WC; Richardson DL; Staley AS; Ahn S; Gehrig PA; Torres D; Dowdy SC; Sullivan MW; Modesitt SC; Watson C; Veade A; Ehrisman J; Havrilesky L; Secord AA; Loreen A; Griffin K; Jackson A; Viswanathan AN; Jager LR; Fader AN
Gynecol Oncol; 2020 Mar; 156(3):568-574. PubMed ID: 31948730
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?
Backes FJ; Felix AS; Plante M; Grégoire J; Sullivan SA; Rossi EC; Tanner EJ; Stewart KI; Soliman PT; Holloway RW; Abu-Rustum NR; Leitao MM
Gynecol Oncol; 2021 May; 161(2):347-352. PubMed ID: 33678480
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion.
Nasioudis D; Oh J; Ko EM; Haggerty AF; Cory L; Giuntoli Ii RL; Kim SH; Morgan MA; Latif NA
Int J Gynecol Cancer; 2022 Jun; ():. PubMed ID: 35649658
[TBL] [Abstract][Full Text] [Related]
18. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
Klopp AH; Jhingran A; Ramondetta L; Lu K; Gershenson DM; Eifel PJ
Gynecol Oncol; 2009 Oct; 115(1):6-11. PubMed ID: 19632709
[TBL] [Abstract][Full Text] [Related]
19. Value of combined adjuvant chemotherapy and radiation on survival for stage III uterine cancer: is less radiation equal to more?
Wang CJ; Christie A; Folkert MR; Xie XJ; Albuquerque K
J Gynecol Oncol; 2018 Jul; 29(4):e49. PubMed ID: 29770620
[TBL] [Abstract][Full Text] [Related]
20. Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer.
Jin M; Hou X; Sun X; Zhang Y; Hu K; Zhang F
Int J Gynecol Cancer; 2019 Oct; 29(8):1264-1270. PubMed ID: 31320487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
